Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting, 23571 [2013-09222]

Download as PDF Federal Register / Vol. 78, No. 76 / Friday, April 19, 2013 / Notices Submit your comments to paperwork@hrsa.gov or mail the HRSA Reports Clearance Officer, Room 10–29, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857. Deadline: Comments on this Information Collection Request must be received within 60 days of this notice. ADDRESSES: Dated: April 12, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–09221 Filed 4–18–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration mstockstill on DSK4VPTVN1PROD with NOTICES Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Council on Blood Stem Cell Transplantation. Date and Time: May 16, 2013, 10:00 a.m. to 4:00 p.m. EST. Place: The meeting will be via audio conference call and Adobe Connect Pro. Status: The meeting will be open to the public. Purpose: Pursuant to Public Law 109– 129, 42 U.S.C. 274k (section 379 of the Public Health Service Act, as amended), the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) advises the Secretary of the Department of Health and Human Services and the Administrator, Health Resources and Services Administration (HRSA), on matters related to the activities of the C.W. Bill Young Cell Transplantation Program (Program) and the National Cord Blood Inventory Program. Agenda: The Council will hear reports from ACBSCT Work Groups including: Cord Blood Thawing and Washing; Access to Transplantation; and Advancing Hematopoietic Stem Cell Transplantation for Hemoglobinopathies. The Council will also hear presentations and discussions on topics including: Accreditation, Adverse Event Reporting, and Unmet Need. Agenda items are subject to change as priorities indicate. After Council discussions, members of the public will have an opportunity to provide comments. Because of the Council’s full agenda and the timeframe in which to cover the agenda topics, public comment may be limited. All public comments will be included in VerDate Mar<15>2010 17:11 Apr 18, 2013 Jkt 229001 the record of the ACBSCT meeting. Meeting summary notes will be posted on HRSA’s Program Web site at https:// bloodcell.transplant.hrsa.gov/ABOUT/ Advisory_Council/. The draft meeting agenda will be posted on https://acbsctmeeting.com/ public/sitePage.aspx?key=Home. Those participating in this meeting should register by visiting https:// acbsctmeeting.com/public/ sitePage.aspx?key=Home. The deadline to register for this meeting is Tuesday, May 14, 2013. For all logistical questions and concerns, please contact Deborah Jones, Meeting Planner, by calling (301) 585–1261 or by sending an email to registration@acbsctmeeting. com. The public can join the meeting by: 1. (Audio Portion) Calling the conference Phone Number 800–857– 9638 and providing the Participant Code 75841; AND 2. (Visual Portion) Connecting to the ACBSCT Adobe Connect Pro Meeting using the following URL: https:// hrsa.connectsolutions.com/acbsctm/ (copy and paste the link into your browser if it does not work directly, and enter as a guest). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connectsolutions.com/ common/help/en/support/ meeting_test.htm and get a quick overview by following URL: https:// www.adobe.com/go/ connectpro_overview. Call (301) 443– 0437 or send an email to ptongele@hrsa.gov if you are having trouble connecting to the meeting site. Public Comment: It is preferred that persons interested in providing an oral presentation submit a written request, along with a copy of their presentation to: Passy Tongele, MBA, Division of Transplantation, Healthcare Systems Bureau, HRSA, 5600 Fishers Lane, Room 12C–06, Rockville, Maryland 20857; or email at ptongele@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may request it at the time of PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 23571 the public comment period. Public participation and ability to comment will be limited to space and time as it permits. For Further Information Contact: Patricia Stroup, MBA, MPA, Executive Secretary, HSB, Healthcare Systems Bureau, 5600 Fishers Lane, Room 12C– 06, Rockville, Maryland 20857; telephone (301) 443–1127. Dated: April 15, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–09222 Filed 4–18–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK Central Repositories Non-renewable Sample Access (X01): Hepatitis C and Type 1 Diabetes Biomarkers. Date: May 9, 2013. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Najma Begum, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 749, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8894, begumn@niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK–KUH Fellowship Review Committee. Date: June 3, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\19APN1.SGM 19APN1

Agencies

[Federal Register Volume 78, Number 76 (Friday, April 19, 2013)]
[Notices]
[Page 23571]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09222]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Council on Blood Stem Cell Transplantation; Notice of 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Council on Blood Stem Cell Transplantation.
    Date and Time: May 16, 2013, 10:00 a.m. to 4:00 p.m. EST.
    Place: The meeting will be via audio conference call and Adobe 
Connect Pro.
    Status: The meeting will be open to the public.
    Purpose: Pursuant to Public Law 109-129, 42 U.S.C. 274k (section 
379 of the Public Health Service Act, as amended), the Advisory Council 
on Blood Stem Cell Transplantation (ACBSCT) advises the Secretary of 
the Department of Health and Human Services and the Administrator, 
Health Resources and Services Administration (HRSA), on matters related 
to the activities of the C.W. Bill Young Cell Transplantation Program 
(Program) and the National Cord Blood Inventory Program.
    Agenda: The Council will hear reports from ACBSCT Work Groups 
including: Cord Blood Thawing and Washing; Access to Transplantation; 
and Advancing Hematopoietic Stem Cell Transplantation for 
Hemoglobinopathies. The Council will also hear presentations and 
discussions on topics including: Accreditation, Adverse Event 
Reporting, and Unmet Need. Agenda items are subject to change as 
priorities indicate.
    After Council discussions, members of the public will have an 
opportunity to provide comments. Because of the Council's full agenda 
and the timeframe in which to cover the agenda topics, public comment 
may be limited. All public comments will be included in the record of 
the ACBSCT meeting. Meeting summary notes will be posted on HRSA's 
Program Web site at https://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/.
    The draft meeting agenda will be posted on https://acbsctmeeting.com/public/sitePage.aspx?key=Home. Those participating in 
this meeting should register by visiting https://acbsctmeeting.com/public/sitePage.aspx?key=Home. The deadline to register for this 
meeting is Tuesday, May 14, 2013. For all logistical questions and 
concerns, please contact Deborah Jones, Meeting Planner, by calling 
(301) 585-1261 or by sending an email to registration@acbsctmeeting.com.
    The public can join the meeting by:
    1. (Audio Portion) Calling the conference Phone Number 800-857-9638 
and providing the Participant Code 75841; AND
    2. (Visual Portion) Connecting to the ACBSCT Adobe Connect Pro 
Meeting using the following URL: https://hrsa.connectsolutions.com/acbsctm/ (copy and paste the link into your browser if it does not work 
directly, and enter as a guest). Participants should call and connect 
15 minutes prior to the meeting in order for logistics to be set up. If 
you have never attended an Adobe Connect meeting, please test your 
connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by 
following URL: https://www.adobe.com/go/connectpro_overview. Call (301) 
443-0437 or send an email to ptongele@hrsa.gov if you are having 
trouble connecting to the meeting site.
    Public Comment: It is preferred that persons interested in 
providing an oral presentation submit a written request, along with a 
copy of their presentation to: Passy Tongele, MBA, Division of 
Transplantation, Healthcare Systems Bureau, HRSA, 5600 Fishers Lane, 
Room 12C-06, Rockville, Maryland 20857; or email at ptongele@hrsa.gov. 
Requests should contain the name, address, telephone number, email 
address, and any business or professional affiliation of the person 
desiring to make an oral presentation. Groups having similar interests 
are requested to combine their comments and present them through a 
single representative.
    The allocation of time may be adjusted to accommodate the level of 
expressed interest. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may request it at 
the time of the public comment period. Public participation and ability 
to comment will be limited to space and time as it permits.
    For Further Information Contact: Patricia Stroup, MBA, MPA, 
Executive Secretary, HSB, Healthcare Systems Bureau, 5600 Fishers Lane, 
Room 12C-06, Rockville, Maryland 20857; telephone (301) 443-1127.

    Dated: April 15, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-09222 Filed 4-18-13; 8:45 am]
BILLING CODE 4165-15-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.